English
Polski
Español
українська
The 3 most important recent advances in the management of systemic lupus erythematosus
Dr Kim Legault from McMaster University presents the 3 most important recent advances in the management of SLE.
2021-09-17
Dr Kim Legault from McMaster University presents the 3 most important recent advances in the management of SLE.
Dr Robert B. M. Landewé from the Amsterdam University Medical Center, The Netherlands, shares his views on the 3 most important recent advances in the management of spondyloarthritis.
Dr Daniel Aletaha shares his views on the 3 most important recent advances in the management of rheumatoid arthritis.
Dr Bhaskar Dasgupta from Southend University Hospital, UK, shares his views on the 3 most important recent advances in the management of systemic lupus erythematosus.
Is age a contraindication to the use of biologic drugs in patients with autoimmune diseases?
What do we know about the risk of cancer associated with biologic therapy?
There has been a growing number of cases of new-onset rheumatoid arthritis in older patients. What are the clues to suspect that joint pain may not be caused by osteoarthritis?
How can we differentiate between a flare of systemic lupus erythematosus (SLE) and an infection?
Are there any laboratory biomarkers or other tools that can distinguish immune-mediated rheumatic diseases from other disorders and from possible complications, such as infections?
What conditions have to be excluded in the diagnostic workup of immune-mediated rheumatic diseases?
